‘Survey’ shows strong voter backing for 340B reforms, with 87% supporting greater transparency and accountability to help lower drug costs.
The American Legislative Exchange Council (ALEC) said the federal 340B Drug Pricing Program may be driving up costs for taxpayers and patients while falling short of helping the underserved communities…
A new Minnesota 340B report suggests the program is generating billion-dollar revenue for hospitals and driving consolidation rather than supporting safety-net care, according to UCSF assistant professor Anthony DiGiorgio.
Sign-up for the Weekly Newsletter from St. Louis Reporter.